Daily Markets Briefing: STI up 0.45%

Don't expect gains today.

The Straits Times Index (STI) ended 15.85 points or 0.45% higher to 3536.41, taking the year-to-date performance to +3.92%.

The top active stocks were Singtel, which gained closed unchanged, DBS, which gained 0.76%, CityDev, which gained 2.45%, OCBC Bank, which gained 0.69% and Keppel Corp, with a 1.63% advance.

The FTSE ST Mid Cap Index declined 0.03%, whilst the FTSE ST Small Cap Index remain unchanged. 

According to OCBC Investment Research, the U.S. stock market was closed on Monday for Martin L. King Day.

European stocks finished lower Monday, as the euro continued to march up further into three-year highs, giving a key regional benchmark its third drop in four sessions.

"With Wall Street closed last night, the local bourse could get off to a muted start this morning," OCBC said.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare